NCT04775446View on ClinicalTrials.gov

Evaluation of the Clinical/Biological Characteristics, Efficacy and Safety of Patients With Malignant Pleural Mesothelioma, Treated by Immunotherapy

CompletedOBSERVATIONAL
Enrollment

116

Participants

Timeline

Start Date

November 26, 2020

Primary Completion Date

October 11, 2021

Study Completion Date

October 11, 2021

Conditions
Malignant Pleural Mesothelioma
Interventions
OTHER

Data collection

Data entered in a secure computer database

Trial Locations (5)

Unknown

CH Côte basque, Bayonne

CHU Brest, Brest

CH Cherbourg, Cherbourg

CHI Créteil, Créteil

CHU Lille, Lille

All Listed Sponsors
lead

Centre Hospitalier Intercommunal Creteil

OTHER

NCT04775446 - Evaluation of the Clinical/Biological Characteristics, Efficacy and Safety of Patients With Malignant Pleural Mesothelioma, Treated by Immunotherapy | Biotech Hunter | Biotech Hunter